Literature DB >> 35029600

Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain.

Lisa Boinon1, Jie Yu1, Cynthia L Madura1, Aude Chefdeville1, Douglas L Feinstein2,3, Aubin Moutal1, Rajesh Khanna1,4.   

Abstract

ABSTRACT: Mechanistic studies principally focusing on primary afferent nociceptive neurons uncovered the upregulation of collapsin response mediator protein 2 (CRMP2)-a dual trafficking regulator of N-type voltage-gated calcium (Cav2.2) as well as Nav1.7 voltage-gated sodium channels-as a potential determinant of neuropathic pain. Whether CRMP2 contributes to aberrant excitatory synaptic transmission underlying neuropathic pain processing after peripheral nerve injury is unknown. Here, we interrogated CRMP2's role in synaptic transmission and in the initiation or maintenance of chronic pain. In rats, short-interfering RNA-mediated knockdown of CRMP2 in the spinal cord reduced the frequency and amplitude of spontaneous excitatory postsynaptic currents, but not spontaneous inhibitory postsynaptic currents, recorded from superficial dorsal horn neurons in acute spinal cord slices. No effect was observed on miniature excitatory postsynaptic currents and inhibitory postsynaptic currents. In a complementary targeted approach, conditional knockout of CRMP2 from mouse neurons using a calcium/calmodulin-dependent protein kinase II alpha promoter to drive Cre recombinase expression reduced the frequency and amplitude of spontaneous excitatory postsynaptic currents, but not miniature excitatory SCss. Conditional knockout of CRMP2 from mouse astrocytes using a glial fibrillary acidic protein promoter had no effect on synaptic transmission. Conditional knockout of CRMP2 in neurons reversed established mechanical allodynia induced by a spared nerve injury in both male and female mice. In addition, the development of spared nerve injury-induced allodynia was also prevented in these mice. Our data strongly suggest that CRMP2 is a key regulator of glutamatergic neurotransmission driving pain signaling and that it contributes to the transition of physiological pain into pathological pain.
Copyright © 2021 International Association for the Study of Pain.

Entities:  

Mesh:

Year:  2022        PMID: 35029600      PMCID: PMC8760468          DOI: 10.1097/j.pain.0000000000002344

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  64 in total

Review 1.  Regulating excitability of peripheral afferents: emerging ion channel targets.

Authors:  Stephen G Waxman; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

2.  CRMP-2 induces axons in cultured hippocampal neurons.

Authors:  N Inagaki; K Chihara; N Arimura; C Ménager; Y Kawano; N Matsuo; T Nishimura; M Amano; K Kaibuchi
Journal:  Nat Neurosci       Date:  2001-08       Impact factor: 24.884

Review 3.  Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain.

Authors:  Hong-Yi Zhou; Shao-Rui Chen; Hui-Lin Pan
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

Review 4.  Molecular mechanisms of CaMKII activation in neuronal plasticity.

Authors:  Charles C Fink; Tobias Meyer
Journal:  Curr Opin Neurobiol       Date:  2002-06       Impact factor: 6.627

5.  Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus.

Authors:  M Scanziani; M Capogna; B H Gähwiler; S M Thompson
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

6.  Antisense oligonucleotides selectively suppress target RNA in nociceptive neurons of the pain system and can ameliorate mechanical pain.

Authors:  Apoorva Mohan; Bethany Fitzsimmons; Hien T Zhao; Yuhong Jiang; Curt Mazur; Eric E Swayze; Holly B Kordasiewicz
Journal:  Pain       Date:  2018-01       Impact factor: 6.961

7.  Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33.

Authors:  Y Goshima; F Nakamura; P Strittmatter; S M Strittmatter
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

8.  Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.

Authors:  Aubin Moutal; Liberty François-Moutal; Joel M Brittain; May Khanna; Rajesh Khanna
Journal:  Front Cell Neurosci       Date:  2015-01-26       Impact factor: 5.505

9.  Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury.

Authors:  Aubin Moutal; Yingshi Ji; Shreya Sai Bellampalli; Rajesh Khanna
Journal:  Mol Brain       Date:  2020-06-22       Impact factor: 4.041

10.  CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain.

Authors:  Lindsey A Chew; Rajesh Khanna
Journal:  Neuronal Signal       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.